BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 2230966)

  • 1. Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
    Bronen RA; Sze G
    J Neurosurg; 1990 Dec; 73(6):820-39. PubMed ID: 2230966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradural spinal cord lesions: Gd-DTPA-enhanced MR imaging.
    Dillon WP; Norman D; Newton TH; Bolla K; Mark A
    Radiology; 1989 Jan; 170(1 Pt 1):229-37. PubMed ID: 2909101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-DTPA in spinal disease.
    Sze G
    Radiol Clin North Am; 1988 Sep; 26(5):1009-24. PubMed ID: 3420235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nuclear magnetic resonance tomography using gadolinium-DTPA in the diagnosis of spinal lesions].
    Fenzl G; Heywang SH; Vogl T
    Rofo; 1988 Apr; 148(4):415-8. PubMed ID: 2834789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in small lesions of the central nervous system. Improvement by gadolinium-DTPA.
    Schroth G; Grodd W; Guhl L; Grauer M; Klose U; Niendorf HP
    Acta Radiol; 1987; 28(6):667-72. PubMed ID: 2962598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of contrast agents in the evaluation of neoplasms of the central nervous system.
    Yuh WT; Fisher DJ; Nguyen HD; Tali ET; Mayr NA
    Top Magn Reson Imaging; 1992 Sep; 4(4):1-6. PubMed ID: 1419031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
    Sze G; Bravo S; Krol G
    Radiology; 1989 Mar; 170(3 Pt 1):849-56. PubMed ID: 2916042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramedullary disease of the spine: diagnosis using gadolinium-DTPA-enhanced MR imaging.
    Sze G; Krol G; Zimmerman RD; Deck MD
    AJR Am J Roentgenol; 1988 Dec; 151(6):1193-204. PubMed ID: 3263773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM
    Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging contrast agents.
    Runge VM
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast enhancement in spinal MR imaging.
    Breger RK; Williams AL; Daniels DL; Czervionke LF; Mark LP; Haughton VM; Papke RA; Coffer M
    AJR Am J Roentgenol; 1989 Aug; 153(2):387-91. PubMed ID: 2750625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of meningeal contrast enhancement on magnetic resonance imaging.
    McKinstry CS; Worthington BS; Niendorf HP; Young IR
    Acta Radiol Suppl; 1986; 369():564-7. PubMed ID: 2980559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
    Higer HP; Just M; Grigat M; Meindl S; Jungke M; Bielke G; Pedrosa P; Kunze S; Voth D
    Rofo; 1988 Mar; 148(3):307-13. PubMed ID: 2832897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of MR contrast in neoplastic disease of the brain.
    Muroff LR; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):137-57. PubMed ID: 7654393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
    Mehta RC; Pike GB; Haros SP; Enzmann DR
    Radiology; 1995 Apr; 195(1):41-6. PubMed ID: 7892492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadopentetate dimeglumine in craniospinal magnetic resonance imaging: common uses and some potential pitfalls.
    Hardjasudarma M
    Can Assoc Radiol J; 1992 Apr; 43(2):100-10. PubMed ID: 1562885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.